CLU and Alzheimer disease: Clusterin appears to be associated with AD risk (Schrijvers et al., 2011); however, it is most likely a compensatory/neuroprotective response (reviewed in: Nuutinen et al., 2009) as it is associated with AD severity, but not with the risk of developing AD at follow up.